As part of our Wealth Creator Series , today we look at Ajanta Pharma. This is one of the 39 stocks that were short-listed that passed through our stringent stock screen filters. Focus on select generics has rewarded Ajanta Pharma with healthy margins whereas entry into the regulated
This article was originally published on August 23, 2012.